Enjoy complimentary customisation on priority with our Enterprise License!
The Global Biosensors Market share is expected to grow by USD 10.85 billion from 2021 to 2026 at a Compound annual growth rate (CAGR) of 7.70%. The growth of the Global Biosensors Market is driven by several key factors reshaping healthcare. Advances in biosensor technology enable more accurate detection of biological markers, while the increasing focus on personalized medicine and wearable health monitoring drives demand for convenient and non-invasive health monitoring solutions. Additionally, the rising demand for point-of-care diagnostics fosters the adoption of biosensors for rapid and decentralized disease detection, underscoring their pivotal role in modern healthcare delivery. This market analysis and report includes in-depth information about the key market drivers, trends, and challenges during the forecasted period.
Download the Free Report Sample!
To gain further insights on the market contribution of various segments Request for a FREE sample
The market share by the wearable segment has been significant. Through these insights, you can safely deduce transformation patterns in consumer behavior, which is crucial to gauge segment-wise revenue during 2022-2026 and embrace technologies to improve business efficiency.
This market forecasting report provides an accurate prediction of the contribution of all the segments to the growth of the market size. Furthermore, our analysts have indicated actionable market insights on the pandemic impact on each segment, which is crucial to predict change in consumer demand.
For more insights on the market share of various regions Request for a FREE sample now!
48% of the market will originate from North America during the forecast period. The US are the key market for the market in North America.
The market growth analysis report offers an up-to-date analysis of the geographical composition of the market. North America has been recording significant rates and is expected to offer several growth opportunities to market companies during the forecast period. The advantages of biosensors in drug analysis will facilitate market growth in North America over the forecast period. The market research and growth report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for companies.
The market is witnessing significant growth driven by technological advancements and strategic endeavors, particularly in medical applications. Compact diagnostic devices, including nanotechnology-based biosensors, are revolutionizing disease prognosis and enhancing patient survival rates. Intricon, through its Biosensors Center of Excellence (CoE), is leading innovation in the medical market. Additionally, they find applications beyond medical settings, such as food analysis, imaging, and microbial activity monitoring, showcasing their versatility and potential impact across various sectors.
This market growth and trends report also provides detailed information on other upcoming market segmentation that will have a far-reaching effect on the market. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
The market research report analyzes the market's competitive landscape and offers information on several market companies, including:
The company landscape of the market entails successful business strategies deployed by the companies. The market is fragmented, and companies are deploying various organic and inorganic growth strategies to compete.
The biosensors market is witnessing rapid development, particularly in medical applications aimed at improving diagnostics and disease prognosis, ultimately enhancing patient survival rates. Technological improvements, including nanotechnology-based biosensors and non-invasive devices, are revolutionizing healthcare. Companies like Intricon and Ethicon Endo-Surgery Inc. are driving innovation through strategic endeavors and research collaborations. Continuous health monitoring, facilitated by devices like Nix Hydration Biosensor, benefits athletes and individuals alike, ensuring timely intervention.
Biosensors, employing various detection principles such as piezoelectric and electrochemical methods, offer exceptional stability and robustness, meeting the stringent requirements of the global healthcare sector. With low detection limits and wide linear response ranges, biosensors enable accurate concentration and kinetic analyses, paving the way for personalized medicine and advanced disease management. The market is witnessing significant growth driven by technological innovation and research collaborations in medical devices and specialty drugs. Companies like Johnson & Johnson Innovation are pioneering the development of non-invasive biosensors, including electromyography (EMG) biosensors, and Bluetooth-enabled reusable modules. They are integrated with mobile apps and single-use patches, offer diabetic patients convenient monitoring solutions.
However, the market faces challenges due to strict regulations and complex cost recovery policies. Government programs support research in proteomics and genomics, while biosensors continue to evolve with advancements in thermal and optical technologies, offering excellent stability, repeatability, and compatibility with new microfabrication technologies. With features like disposability and low power needs, biosensors find applications in fermentation monitoring, structural research, and kinetic analysis and equilibrium analysis, facilitating receptor-cell interactions and driving market growth.
Biosensors Market Scope |
|
Market Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.70% |
Market growth 2022-2026 |
USD 10.85 billion |
Market structure |
Fragmented |
YoY growth (%) |
5.96 |
Regional analysis |
North America, Europe, APAC, South America, and MEA |
Performing market contribution |
North America at 48% |
Key consumer countries |
US, Germany, Japan, UK, and France |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Companies profiled |
Abbott Laboratories, Bio Rad Laboratories Inc., Biosensors-International Group Ltd., Cytiva, Dexcom Inc., DuPont de Nemours Inc., LifeScan IP Holdings LLC, Masimo Corp., Medtronic Plc, and Universal Biosensors-Group |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our market trends and analysis report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.